Innovative Technology for Blood Recycling.
Main Markets:
Hospital departments: Neonatal Intensive Care Unit and Children's Intensive Care Unit.
Overview
ERYTHROSAVE is developing an innovative device and method for
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
immediate return of red blood cells taken for laboratory testing
from premature babies or infants in intensive care.
Many blood samples for laboratory testing are required from
premature babies with birth weight of 1.5 kg. (3 lb, 5 oz.) and
less (before 32nd week) and infants in intensive care. The
quantity of blood taken is sufficient to bring about anemia. In
order to return blood that was taken, according to standard
criteria, three units of blood are returned to the infant.
Today, as a rule, thirty blood samples are taken in the first
week of the life of the premature infant and three transfusions
of blood from the Blood Bank replace the blood taken.
The goal of the project is to develop a system and devices that
will enable separation of red blood cells from plasma in order to
return them immediately to the infant and at the same time send
the plasma for laboratory testing. This will enable reduction of
50% of the blood transfusions required today.
